Scott DesJarlais said...
The bottom line is you took a very inexpensive drug and you profited handsomely off it.
Context
DesJarlais criticizes the high pricing of EpiPens despite their low cost.
09/20/2016
DesJarlais criticizes the high pricing of EpiPens despite their low cost.
09/20/2016